Cargando…
Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
SARS-CoV-2 is a positive single-strand RNA-based macromolecule that has caused the death of more than 6.3 million people since June 2022. Moreover, by disturbing global supply chains through lockdowns, the virus has indirectly caused devastating damage to the global economy. It is vital to design an...
Autores principales: | Aqeel, Imra, Bilal, Muhammad, Majid, Abdul, Majid, Tuba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695639/ https://www.ncbi.nlm.nih.gov/pubmed/36355505 http://dx.doi.org/10.3390/ph15111333 |
Ejemplares similares
-
An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1
por: Subramanian, Umadevi, et al.
Publicado: (2014) -
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2020) -
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021) -
Analysis of the uncharted, druglike property space by self-organizing maps
por: Takács, Gergely, et al.
Publicado: (2021) -
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)